IDSK -- The cost of colorectal cancer screening could be cut substantially without impairing its effectiveness by adopting a “resect and discard” approach for the smallest polyps, Dr. Cesare Hassan and his colleagues said in an article appearing in the October issue of Clinical Gastroenterology and Hepatology (doi: 10.1016/j.cgh.2010.05.018).